Alzheimer disease research is yielding breakthroughs with blood tests and brain scans that can enhance early diagnosis, while ...
Payers must continue to assess their prior authorization practices to uphold the goals of clinical quality, safety, and ...
Patients With Vitiligo Experience Poorer Quality of Life but Greater Health Care Access, Utilization
Compared with those without vitiligo, patients with vitiligo have higher health care access and utilization but report a ...
Patients who had weight-loss surgery were more likely to have managed their high blood pressure compared with those who used ...
The trend of food insecurity continued in 2023, according to a report from the Department of Agriculture. The trend of food ...
A new formulation of treprostinil (Yutrepia) could soon be available to patients with pulmonary arterial hypertension (PAH) ...
Recombinant Hirudin (rH) inhibited the polarization of M2-type macrophages and protease-activated receptor-1 (PAR-1) in ...
A review by authors from China examines evidence involving different treatment approaches.
Treating and preventing correctable vision impairments could prevent up to 19% of dementia prevalence, according to a new ...
This interview accompanies the first podcast in our National Recovery Month series with Michael Lynch, MD, attending emergency physician and medical toxicologist at the University of Pittsburgh ...
The FINEARTS-HF late-breaking data were forefront at the 2024 European Society of Cardiology Congress in London.
Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, emphasizes the need for better prevention of cardiovascular risks and discusses upcoming advances in glucagon-like peptide 1 (GLP-1) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results